Rothschild & Co Asset Management US’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-734,267	Closed	-$17.4M	–	365
2019 Q4	$17.4M	Sell	734,267 -36,695	-5%	-$891K	0.18%	205
2019 Q3	$21.2M	Sell	770,962 -10,964	-1%	-$325K	0.23%	183
2019 Q2	$25.9M	Sell	781,926 -66,873	-8%	-$2.29M	0.28%	156
2019 Q1	$29.7M	Sell	848,799 -2,684	-0.3%	-$99.9K	0.32%	117
2018 Q4	$28.3M	Buy	851,483 +15,455	+2%	+$665K	0.34%	107
2018 Q3	$42.1M	Sell	836,028 -21,092	-2%	-$1.04M	0.43%	71
2018 Q2	$51.3M	Sell	857,120 -222,668	-21%	-$11.5M	0.55%	44
2018 Q1	$49.5M	Sell	1,079,788 -7,627	-0.7%	-$318K	0.55%	47
2017 Q4	$43.3M	Sell	1,087,415 -39,803	-4%	-$1.57M	0.46%	66
2017 Q3	$45.1M	Sell	1,127,218 -45,647	-4%	-$1.98M	0.5%	58
2017 Q2	$50.5M	Buy	1,172,865 +43,007	+4%	+$1.53M	0.57%	46
2017 Q1	$35.4M	Buy	1,129,858 +35,981	+3%	+$964K	0.41%	71
2016 Q4	$27.6M	Buy	1,093,877 +148,520	+16%	+$3.32M	0.35%	88
2016 Q3	$23.4M	Buy	945,357 +52,806	+6%	+$1.2M	0.4%	83
2016 Q2	$18.2M	Buy	892,551 +110,320	+14%	+$1.96M	0.33%	104
2016 Q1	$11.9M	Buy	782,231 +118,482	+18%	+$1.55M	0.22%	155
2015 Q4	$8.92M	Buy	663,749 +72,920	+12%	+$1.13M	0.16%	203
2015 Q3	$8.29M	Buy	590,829 +203,875	+53%	+$3.79M	0.16%	207
2015 Q2	$6.57M	Buy	+386,954	New	+$5.51M	0.12%	239